Skip to main content

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 229))

  • 128 Accesses

Abstract

Over the last 10 years rapid advances in molecular biology have led to a much greater understanding of several important cardiac disorders. It is likely that over the next ten years great advances in management of these patients will occur as a result of further advances in molecular medicine. The moleculoar genetic basis of hypertrophic cardiomyopathy and some forms of dilated cardiomyopathy are known, as well as long QT syndrome and Marfans syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference List

  1. Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, Bonne, Guicheney P, Hainque B, Bouhour JB, et al. Penetrance of familial hypertrophic cardiomyopathy. Genet.Couns. 1997;8(2):107–14.

    PubMed  CAS  Google Scholar 

  2. Landing BH, Recalde AL, Lawrence TK, Shankle WR. Cardiomyopathy in childhood and adult life, with emphasis on hypertrophic cardiomyopathy. Pathol. Res. Pract. 1994;190(8):737–49.

    Article  PubMed  CAS  Google Scholar 

  3. Ryan MP, Cleland JF, French JA, Joshi J, Choudhury L, Chojnowska L, Michalak E, Al-Mahdawi S, Nihoyannopoulos P, Oakley CM. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am.J.Cardiol. 1995;76(10):689–94.

    Article  PubMed  CAS  Google Scholar 

  4. Solomon SD, Wolff S, Watkins H, Ridker PM, Come P, McKenna WJ. Seidman, CE, Lee RT. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J.Am.Coll.Cardiol. 1993;22(2):498–505.

    Article  PubMed  CAS  Google Scholar 

  5. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O’Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopat. N. Engl. J. Med. 1995; 332(16):1058–64.

    Article  PubMed  CAS  Google Scholar 

  6. Anan R, Greve G, Thierfelder L, Watkins H, McKenna WJ, Solomon S, Vecchio C, Shono H, Nakao S, Tanaka H, et al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopath. J.Clin.Invest. 1994;93(l):280–5.

    Article  PubMed  CAS  Google Scholar 

  7. Yu B, French JA, Jeremy RW, French P, McTaggart DR, Nicholson MR, Semsarian C, Richmond DR, Trent RJ. Counselling issues in familial hypertrophic cardiomyopathy. J Med Genetic 1998;35(3): 183–8.

    Article  CAS  Google Scholar 

  8. Lankford EB, Epstein ND, Fananapazir L, Sweeney HL. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J.Clin.Invest. 1995;95(3): 1409–14.

    Article  PubMed  CAS  Google Scholar 

  9. Golitsina N, An Y, Greenfield NJ, Thierfelder L, Iizuka K, Seidman JG, Seidman CE, Lehrer SS, Hitchcock-DeGregori SE. Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function. Biochemistry 1997;36(15):4637–42.

    Article  PubMed  CAS  Google Scholar 

  10. Yoneya K, Okamoto H, Machida M, Onozuka H, Noguchi M, Mikami T, Kawaguchi H, Murakami M, Uede T, Kitabatake A. Angiotensin-Converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am.Heart J. 1995; 130(5): 1089–93.

    Article  PubMed  CAS  Google Scholar 

  11. Geisterfer-Lowrance AT, Kass S, Tanigawa G, Vosberg H-P, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell 1990;62(5):999–1006.

    Article  PubMed  CAS  Google Scholar 

  12. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg, Seidman JG, Seidman CE. Alpha-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcome. Cell 1994;77(5):701–12.

    Article  PubMed  Google Scholar 

  13. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat.Genet 1995; 11(4):434–7.

    Article  PubMed  CAS  Google Scholar 

  14. Kimura A, Harada H, Park J-E, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat.Genet. 1997;16(4):379–82.

    Article  PubMed  CAS  Google Scholar 

  15. MacRae CA, Ghaisas N, Kass S, Donnelly S, Basson CT, Watkins HC, Anan,, Thierfelder LH, McGarry K, Rowland E, et al. Familial hypertrophie cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J.Clin.Invest. 1995;96(3): 1216–20.

    Article  PubMed  CAS  Google Scholar 

  16. Shibata M, Yamakado T, Imanaka-Yoshida K, Isaka N, Nakano T. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome progressing to ventricular dilation. Am.Heart J. 1996; 131(6): 1223–5.

    Article  PubMed  CAS  Google Scholar 

  17. Muntoni F, Di Lenarda A, Porcu M, Sinagra G, Mateddu A, Marrosu G, Ferlini A, Cau M, Milasin J, Melis MA, et al. Dystrophin gene abnormalities in two patients with idiopathic dilated cardioyopathy. Heart 1997;78(6):608–12.

    PubMed  CAS  Google Scholar 

  18. Towbin JA. The role of cytoskeletal proteins in cardiomyopathies. Current Opin Cell Biol 1998;10(l):131–9.

    Article  CAS  Google Scholar 

  19. Olson TM, Keating MT. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest 1996;97(2):528–32.

    Article  PubMed  CAS  Google Scholar 

  20. Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker IIP, Cody RJ, Fishman MC, et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome lpl-lql. Nature Genetics 1994;7(4): 546–51.

    Article  PubMed  CAS  Google Scholar 

  21. Durand J-B, Bachinski LL, Bieling LC, Czernuszewicz GZ, Abchee AB, Qun TY, Tapscott T, Hill R, Ifegwu J, Marian AJ, et al. Localization of a gene responsible for familial dilated cardiomyopathy to chromosome lq32. Circulation 1995;92(12):3387–9.

    Article  PubMed  CAS  Google Scholar 

  22. Krajinovic M, Pinamonti B, Sinagra G, Vatta M, Severini GM, Milasin J, Falaschi A, Camerini F, Giacca M, Mestroni L, et al. Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Gen 1995;57(4):846–52.

    CAS  Google Scholar 

  23. Bowles KR, Gajarski R, Porter P, Goytia V, Bachinski L, Roberts R, Pignatelli R, Towbin JA. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest 1996;98(6): 1355–60.

    Article  PubMed  CAS  Google Scholar 

  24. Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomstrom-Lundqvist C, Wlodarska EK, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study. J.Am.Coll.Cardiol. 1997;30(6): 1512–20.

    Article  PubMed  CAS  Google Scholar 

  25. Marcus FI, Fontaine G. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: A review. Pacing Clin.Electrophysiol. 1995; 18(6): 1298–314.

    Article  PubMed  Google Scholar 

  26. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br.Heart J. 1994;71(3):215–8.

    Article  PubMed  CAS  Google Scholar 

  27. Nava A, Canciani B, Thiene G, Scognamiglio R, Buja G, Martini B, Daliento L, Fasoli G, Stritoni P, Dalla VS. Analysis of the mode of transmission of right ventricular dysplasia. Arch.Mal.Coeur Vaiss. 1990;83(7):923–8.

    PubMed  CAS  Google Scholar 

  28. Coonar A, Protonotarios N, Tsatsopoulou A, Needham S, Houlston R, Cliff S, Otter M, Murday V, Mattu R, McKenna WJ. Gene for Arrhythmogenic Right Ventricular Cardiomyopathy with diffuse nonepidermolytic palmoplanar keratoderma and woolly hair (Naxos Disease) maps to 17q21. Circulation 1998;97(20):2049

    Google Scholar 

  29. Rampazzo A, Nava A, Danieli GA, Buja G, Daliento L, Fasoli G, Scognamiglio R, Corrado D, Thiene G. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum.Mol.Genet. 1994;3(6):959–62.

    Article  PubMed  CAS  Google Scholar 

  30. Rampazzo A, Nava A, Erne P, Eberhard M, Vian E, Slomp P, Tiso N, Thiene G, Danieli GA. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum.Mol.Genet. 1995;4(11):2151–4.

    Article  PubMed  CAS  Google Scholar 

  31. Rampazzo A, Nava A, Miorin M, Fonderico P, Pope B, Tiso N, Livolsi B, Zimbello R, Thiene G, Danieli GA. ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. Genomics 1997;45(2):259–63.

    Article  PubMed  CAS  Google Scholar 

  32. Severini GM, Krajinovic M, Pinamonti B, Sinagra G, Fioretti P, Brunazzi, MC, Falaschi A, Camerini F, Giacca M, et al. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 1996;31(2): 193–200.

    Article  PubMed  CAS  Google Scholar 

  33. Tomita Y, Iijima M. Romano-Ward syndrome. Ryoikibetsu Shokogun Shirizu 1996;(12):211–4.

    Google Scholar 

  34. Aoki T. Jervell and Lange-Nielsen syndrome. Ryoikibetsu Shokogun Shirizu 1996;(12):188–91.

    Google Scholar 

  35. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, Grancini F, Marni E, Perticone F, Rosti D, et al. Prolongation of the QT Interval and the Sudden Infant Death Syndrome. N.Engl.J.Med 1998;338(24): 1709–14.

    Article  PubMed  CAS  Google Scholar 

  36. Ackerman MJ. The long QT syndrome: Ion channel diseases of the heart. Mayo Clinic Proceedings 1998;73(3):250–69.

    Article  PubMed  CAS  Google Scholar 

  37. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80(5):805–11.

    Article  PubMed  CAS  Google Scholar 

  38. Satler CA, Walsh EP, Vesely MR, Plummer MH, Ginsburg GS, Jacob HJ. Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome. Am.J.Med Genet. 1996;65(l):27–35.

    Article  PubMed  CAS  Google Scholar 

  39. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat.Genet. 1997; 15(2): 186–9.

    Article  PubMed  CAS  Google Scholar 

  40. Duggal P, Vesely MR, Wattanasirichaigoon D, Villafane J, Kaushik V, Beggs AH. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. Circulation 1998;97(2): 142–6.

    Article  PubMed  CAS  Google Scholar 

  41. Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, Bennaceur M, Chivoret G, Schwartz K, Coumel P, Guicheney P. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997;96(9):2778–81.

    Article  PubMed  CAS  Google Scholar 

  42. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80(5):795–803.

    Article  PubMed  CAS  Google Scholar 

  43. Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, Schwartz PJ, Towbin JA, Vincent GM, Lehmann MH. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92(10):2929–34.

    Article  PubMed  CAS  Google Scholar 

  44. Priori SG, Napolitano C, Cantu F, Brown AM, Schwartz PJ. Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ.Res. 1996;78(6):1009–15.

    Article  PubMed  CAS  Google Scholar 

  45. Keene DR, Jordan CD, Reinhardt DP, Ridgway CC, Ono RN, Corson GM, Fairhurst M, Sussman MD, Memoli VA, Sakai LY. Fibrillin-1 in human cartilage: developmental expression and formation of special banded fibers. J.Histochem.Cytochem. 1997;45(8): 1069–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Norman, M.W., D’Cruz, L.G., Mahon, N., McKenna, W.J. (2000). Cardiovascular Molecular Genetics. In: Osterhues, HH., Hombach, V., Moss, A.J. (eds) Advances in Noninvasive Electrocardiographic Monitoring Techniques. Developments in Cardiovascular Medicine, vol 229. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4090-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4090-4_1

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5796-7

  • Online ISBN: 978-94-011-4090-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics